236 related articles for article (PubMed ID: 33290579)
61. A novel concept to include uncertainties in the evaluation of stereotactic body radiation therapy after 4D dose accumulation using deformable image registration.
Azcona JD; Huesa-Berral C; Moreno-Jiménez M; Barbés B; Aristu JJ; Burguete J
Med Phys; 2019 Oct; 46(10):4346-4355. PubMed ID: 31402461
[TBL] [Abstract][Full Text] [Related]
62. Measurement of lung tumor motion using respiration-correlated CT.
Mageras GS; Pevsner A; Yorke ED; Rosenzweig KE; Ford EC; Hertanto A; Larson SM; Lovelock DM; Erdi YE; Nehmeh SA; Humm JL; Ling CC
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):933-41. PubMed ID: 15465212
[TBL] [Abstract][Full Text] [Related]
63. A method for deriving a 4D-interpolated balanced planning target for mobile tumor radiotherapy.
Roland T; Hales R; McNutt T; Wong J; Simari P; Tryggestad E
Med Phys; 2012 Jan; 39(1):195-205. PubMed ID: 22225288
[TBL] [Abstract][Full Text] [Related]
64. Modeling pancreatic tumor motion using 4-dimensional computed tomography and surrogate markers.
Huguet F; Yorke ED; Davidson M; Zhang Z; Jackson A; Mageras GS; Wu AJ; Goodman KA
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):579-87. PubMed ID: 25680600
[TBL] [Abstract][Full Text] [Related]
65. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
[TBL] [Abstract][Full Text] [Related]
66. Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes.
Callahan J; Kron T; Siva S; Simoens N; Edgar A; Everitt S; Schneider ME; Hicks RJ
Radiat Oncol; 2014 Dec; 9():291. PubMed ID: 25511904
[TBL] [Abstract][Full Text] [Related]
67. Real-time 4DMRI-based internal target volume definition for moving lung tumors.
Rabe M; Thieke C; Düsberg M; Neppl S; Gerum S; Reiner M; Nicolay NH; Schlemmer HP; Debus J; Dinkel J; Landry G; Parodi K; Belka C; Kurz C; Kamp F
Med Phys; 2020 Apr; 47(4):1431-1442. PubMed ID: 31955430
[TBL] [Abstract][Full Text] [Related]
68. Reconstruction of a time-averaged midposition CT scan for radiotherapy planning of lung cancer patients using deformable registration.
Wolthaus JW; Sonke JJ; van Herk M; Damen EM
Med Phys; 2008 Sep; 35(9):3998-4011. PubMed ID: 18841851
[TBL] [Abstract][Full Text] [Related]
69. Dynamic volume vs respiratory correlated 4DCT for motion assessment in radiation therapy simulation.
Coolens C; Bracken J; Driscoll B; Hope A; Jaffray D
Med Phys; 2012 May; 39(5):2669-81. PubMed ID: 22559637
[TBL] [Abstract][Full Text] [Related]
70. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
[TBL] [Abstract][Full Text] [Related]
71. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
Gerlich AS; van der Velden JM; Kotte ANTJ; Tseng CL; Fanetti G; Eppinga WSC; Kasperts N; Intven MPW; Pameijer FA; Philippens MEP; Verkooijen HM; Seravalli E
Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
[TBL] [Abstract][Full Text] [Related]
72. Correspondence model-based 4D VMAT dose simulation for analysis of local metastasis recurrence after extracranial SBRT.
Sothmann T; Gauer T; Wilms M; Werner R
Phys Med Biol; 2017 Nov; 62(23):9001-9017. PubMed ID: 29059054
[TBL] [Abstract][Full Text] [Related]
73. A novel four-dimensional radiotherapy method for lung cancer: imaging, treatment planning and delivery.
Alasti H; Cho YB; Vandermeer AD; Abbas A; Norrlinger B; Shubbar S; Bezjak A
Phys Med Biol; 2006 Jun; 51(12):3251-67. PubMed ID: 16757875
[TBL] [Abstract][Full Text] [Related]
74. Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-
Wee CW; An HJ; Kang HC; Kim HJ; Wu HG
Technol Cancer Res Treat; 2018 Jan; 17():1533033818787383. PubMed ID: 30012039
[TBL] [Abstract][Full Text] [Related]
75. Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration.
Jasper K; Liu B; Olson R; Matthews Q
Adv Radiat Oncol; 2021; 6(6):100750. PubMed ID: 34401609
[TBL] [Abstract][Full Text] [Related]
76. Preliminary study of the internal margin of the gross tumor volume in thoracic esophageal cancer.
Li J; Wang L; Wang X; Zhao Y; Liu D; Chen C; Zhang HP; Pan J
Cancer Radiother; 2012 Oct; 16(7):595-600. PubMed ID: 23079507
[TBL] [Abstract][Full Text] [Related]
77. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
78. Deep learning based automatic internal gross target volume delineation from 4D-CT of hepatocellular carcinoma patients.
Yang Z; Yang X; Cao Y; Shao Q; Tang D; Peng Z; Di S; Zhao Y; Li S
J Appl Clin Med Phys; 2024 Jan; 25(1):e14211. PubMed ID: 37992226
[TBL] [Abstract][Full Text] [Related]
79. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers.
Chan MK; Kwong DL; Ng SC; Tam EK; Tong AS
Med Phys; 2012 Sep; 39(9):5479-87. PubMed ID: 22957615
[TBL] [Abstract][Full Text] [Related]
80. Design of 4D treatment planning target volumes.
Rietzel E; Liu AK; Doppke KP; Wolfgang JA; Chen AB; Chen GT; Choi NC
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):287-95. PubMed ID: 16904528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
